Literature DB >> 16322412

Current role of magnetic resonance imaging in breast imaging: a primer for the primary care physician.

Shinil K Shah1, Shiwan K Shah, Kathleen V Greatrex.   

Abstract

Magnetic resonance imaging (MRI) is a widely used imaging tool. Interest in the applicability of this modality in the realm of breast imaging has been steadily increasing over the past 25 years. The purpose of this article is to explore the use of contrast-enhanced MRI in breast imaging as it relates to the primary care physician. The mechanism, factors affecting image quality, basics of interpretation guidelines, and the uses and contraindications for this technique are explored. In addition, studies exploring the use of MRI in various areas of breast imaging are presented. It is hoped that the reader will become knowledgeable in the current utility of the tool as it relates to breast imaging.

Mesh:

Substances:

Year:  2005        PMID: 16322412     DOI: 10.3122/jabfm.18.6.478

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  4 in total

1.  The Role of MR Mammography in Differentiating Benign from Malignant in Suspicious Breast Masses.

Authors:  Padhmini Balasubramanian; Vijaya Karthikeyan Murugesan; Vinoth Boopathy
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Choice of management of southern Chinese BRCA mutation carriers.

Authors:  Ava Kwong; Connie H N Wong; Catherine Shea; Dacita T K Suen; Catherine L Y Choi
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer.

Authors:  Aoi Matsuoka; Masako Minato; Masafumi Harada; Hitoshi Kubo; Yoshikatsu Bandou; Akira Tangoku; Kiichirou Nakano; Hiromu Nishitani
Journal:  Radiat Med       Date:  2008-01-31

4.  Establishing a program for individuals at high risk for breast cancer.

Authors:  Fernando Cadiz; Henry M Kuerer; Julio Puga; Jamile Camacho; Eduardo Cunill; Banu Arun
Journal:  J Cancer       Date:  2013-07-01       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.